<DOC>
	<DOCNO>NCT02640794</DOCNO>
	<brief_summary>The purpose study compare aspirin/acetylsalicylic acid+ clopidogrel aspirin/acetylsalicylic acid alone antithrombotic treatment follow TAVI prevention major ischemic event ( MI , ischemic stroke ) death without increase risk major bleed event .</brief_summary>
	<brief_title>Aspirin Versus Aspirin+Clopidogrel Antithrombotic Treatment Following TAVI</brief_title>
	<detailed_description>Transcatheter aortic valve implantation ( TAVI ) emerge alternative standard aortic valve replacement treatment patient consider high prohibitive surgical risk . Nowadays procedure associate high success rate ( &gt; 95 % ) major peri-procedural ischemic complication myocardial infarction ( MI ) ischemic stroke occur 2 % ( 0 % 17 % ) 3 % ( 2 % 7 % ) case , respectively . The recently publish PARTNER trial show stroke rate high 6.5 % within 30 day follow TAVI , ( 77 % ) event diagnose major stroke . In order avoid ischemic complication full dose anticoagulation ( usually intravenous heparin ) administer TAVI procedure , whereas aspirin ( long-term ) + clopidogrel ( 1 6 month ) recommend antithrombotic treatment follow procedure . However , antithrombotic regime recommend empirical basis , study yet show efficacy aspirin + clopidogrel vs. aspirin alone antithrombotic treatment prevent ischemic event follow TAVI procedure . Also , patient undergo TAVI nowadays usually octogenarians frequently exhibit comorbidities hypertension , abnormal renal function prior cerebrovascular disease , significantly increase risk major bleeding . Indeed , TAVI procedures also associate major vascular complication turn complicate life-threatening major bleeding . It well know clopidogrel top aspirin associate high rate major bleeding complication , especially elderly patient . It would therefore major clinical relevance determine risk/benefit ratio use dual antithrombotic therapy follow TAVI procedure order recommend appropriate antithrombotic treatment high-risk population . The ARTE trial multicenter randomize study evaluate efficacy safety aspirin/acetylsalicylic acid versus aspirin/acetylsalicylic acid+ clopidogrel antithrombotic treatment TAVI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patients undergo TAVI procedure Edwards valve . Need chronic anticoagulation treatment Major bleed within 3 month prior TAVI procedure Prior intracranial bleeding Drugeluting stent implantation within year prior TAVI procedure Allergy clopidogrel and/or aspirin/acetylsalicylic acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Transcatheter aortic valve implantation</keyword>
	<keyword>Antithrombotic treatment</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Aspirin/acetylsalicylic acid</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Ischemic stroke</keyword>
	<keyword>Major bleeding</keyword>
</DOC>